Phenotype measures set

ID, description, units MPD:52453   monocytes, percent viability   [%]
idarubicin study
Measures • dose [µM]:    • control    • 0.046    • 0.137    • 1.235    • 11.1    • 100
Data set, strains Wiltshire4   inbred w/CC7   35 strains     sex: m     age: 10wks
Procedure immune cell quantification
Comparisoncontrol group as well as two or more dosage groups
Ontology mappings



Dimensions Width:  ×  Height: px
Values
Graph Type
Plot Options
Download Plot   

Wiltshire4 - monocytes, percent viability

Female

Male



  RM-ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 5 850873.0713 170174.6143 1243.9574 < 0.0001
strain 34 59407.9408 1747.2924 12.7725 < 0.0001
dose:strain 170 81745.2836 480.8546 3.515 < 0.0001
Residuals 608 83175.0051 136.801

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDDrug or
challenge
Description and varname PanelNo.
strains
SexAge
Wiltshire4 52453 immune cell quantification idarubicin monocytes, percent viability   [%]   control   monocytes_Ida_ctrl inbred w/CC7 35 m 10wks
Wiltshire4 52454 immune cell quantification idarubicin monocytes, percent viability   [%]   dose: 0.046 µM   monocytes_Ida_A inbred w/CC7 35 m 10wks
Wiltshire4 52455 immune cell quantification idarubicin monocytes, percent viability   [%]   dose: 0.137 µM   monocytes_Ida_B inbred w/CC7 35 m 10wks
Wiltshire4 52456 immune cell quantification idarubicin monocytes, percent viability   [%]   dose: 1.235 µM   monocytes_Ida_C inbred w/CC7 35 m 10wks
Wiltshire4 52457 immune cell quantification idarubicin monocytes, percent viability   [%]   dose: 11.1 µM   monocytes_Ida_D inbred w/CC7 35 m 10wks
Wiltshire4 52458 immune cell quantification idarubicin monocytes, percent viability   [%]   dose: 100 µM   monocytes_Ida_E inbred w/CC7 35 m 10wks